Identification and validation of a lactylation-related prognostic signature and the role of MELTF as a novel biomarker in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is a major cause of cancer death. While treatments exist, we still lack reliable tools to predict which patients will do well or respond to specific therapies like immunotherapy. Tumor cells often produce large amounts of lactate, a metabolic byproduct. This lactate can drive a newly di...